1,721,092 research outputs found
Molecole leganti il recettore di BAG3 per uso terapeutico
The present invention relates to the use of BAG3 receptor-binding molecules as a medicament, in particular for use in the treatment of diseases of an immune, inflammatory, cardiovascular, neoplastic and/or degenerative nature
Marcatore biochimico serico
The present invention relates to a method for detecting the presence and/or concentration of the soluble BAG3 protein in an unknown biological sample and the assay is preferably carried out by ELISA assay with antibodies, preferably monoclonal antibodies.
The presence of said protein in a soluble form is associated with heart disease or with the presence of pancreatic tumors
Bag3 RNA as biochemical serum and tissue marker
The present disclosure concerns the field of diagnostic biological markers. Specifically the invention relates to BAG3 RNA or a fragment thereof for use as biological markers for the diagnosis of a pathological state. Furthermore, the disclosure involves specific kits and methods, for detecting and/or evaluating the levels of BAG3 RNA or a fragment thereof in a biological sample
Biochemical serum marker
The present invention relates to a method for detecting the presence and/or concentration of the soluble BAG3 protein in an unknown biological sample and the assay is preferably carried out by ELISA assay with antibodies, preferably monoclonal antibodies. The presence of said protein in a soluble form is associated with heart disease or with the presence of pancreatic tumors
Antibodies anti-Bag3 as biochemical serum and tissue marker
The present disclosure concerns the field of diagnostic biological markers. Specifically the disclosure relates to anti-BAG3 antibodies for use as biological markers for the diagnosis of a pathological state. Furthermore, the disclosure involves specific ELISA methods and kits, for detecting and evaluating, anti-BAG3 antibodies or BAG3/antibody complexes in a biological sample
anticorpi anti-BAG3 per uso terapeutico
The present invention relates to the use of BAG3 antibodies as a medicament, particular for use in the treatment of pancreatic tumours or other pathologies of immune, inflammatory, neoplastic and/or degenerative nature
- Appl. N. 01830834.6, December 28, 2001: Leone A, Turco MC: BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death- involving diseases, and for modulation of cell survival and/or death.
Anticorpi BAG3 da utilizzare nella ricerca, nella diagnostica e nella terapia di malattie che comportano la morte cellulare.
The present invention provides BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for modulation of cell survival and/or death, in particular in leukemias, other neoplasias and apoptosis-involving diseases. More particularly the invention refers to the use of specific antisense~-based constructs and peptide-specific polyclonal and monoclonal antibodies in leukemias, other neoplasias and cell death- involving diseases
Monoclonal antibodies recognizing BAG3 protein sequences and their use in diagnostic and therapy of cell death- involving diseases
BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death- involving diseases, and for modulation of cell survival and/or death.
The present invention provides BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for modulation of cell survival and/or death, in particular in leukemias, other neoplasias and apoptosis-involving diseases
- …
